Friday - May 9, 2025

LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Repligen (NASDAQ: RGEN)

Follow NASDAQ:RGEN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ RGEN Repligen
Bylund James / officer: Chief Operating Officer
04/01/2025
Sell
$128.50
454
$58K
23,711
NASDAQ RGEN Repligen
Bylund James / officer: Chief Operating Officer
03/13/2025
Sell
$142.44
175
$25K
24,165
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$33.87
5,000
$169K
202,344
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Buy
$59.52
21,756
$1.295M
163,057
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$148.05
60
$9K
162,997
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$150.38
100
$15K
162,897
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$151.09
2,518
$380K
160,379
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$151.96
6,176
$939K
154,203
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Buy
$33.87
5,000
$169K
141,301
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$152.82
15,619
$2.387M
138,584
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$153.70
2,283
$351K
136,301
NASDAQ RGEN Repligen
Hunt Anthony / director
03/17/2025
Sell
$59.52
21,756
$1.295M
0
NASDAQ RGEN Repligen
Pax Margaret / director
03/17/2025
Buy
$150.69
250
$38K
1,043

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous